The global life science services market continues to attract significant capital flows, albeit at a moderated pace from recent highs seen during the COVID-19 pandemic. The outsourced services industry continues to consolidate at a steady clip, with companies emerging from a tougher operating environment over the past several quarters. Read more about our key perspectives on the market dynamics, growth drivers, and valuation considerations, including recent precedent M&A transactions: https://hubs.li/Q02fQpqS0
Edgemont Partners
Investment Banking
New York, NY 8,788 followers
Transforming Vision into Value
About us
Edgemont Partners is a premier investment bank that provides merger and acquisition advisory and growth capital raising services exclusively to healthcare companies. We focus solely on providing expert strategic advice and transaction execution, bringing a steadfast commitment to our clients, driven always by what’s in their best interest. This dedication enables us to deliver independent conflict-free advice, to serve as trusted advisors to healthcare entrepreneurs, management teams and investors, and to execute with exceptional results.
- Website
-
https://www.edgemont.com/
External link for Edgemont Partners
- Industry
- Investment Banking
- Company size
- 11-50 employees
- Headquarters
- New York, NY
- Type
- Partnership
- Founded
- 2001
Locations
-
Primary
787 7th Ave
49th Floor
New York, NY 10019, US
Employees at Edgemont Partners
Updates
-
Edgemont Managing Directors, Andrew R. Karlin and Sam Fertitta, were recently quoted in PitchBook's inaugural industry primer on the pharmaceutical services sector. Read the full report below. https://hubs.li/Q02K2tb70
Q1 2024 Launch Report: Pharma Services | PitchBook
pitchbook.com
-
The global CDMO market is estimated to be an $80 billion industry, experiencing an 11%+ CAGR. The United States leads as the largest market, valued at $23 billion, and is anticipated to sustain double-digit growth over the next five years. This growth is propelled by several factors, including the rise in robotic and minimally invasive surgeries, a shift towards local sourcing, and the consolidation of OEM suppliers. M&A remains robust in both activity and valuation, highlighted by the formation of over 15 private equity-backed medtech platforms since 2020. These platforms are actively pursuing a roll-up strategy, acquiring small CDMOs to augment their growth trajectory and expand their capabilities. Read more about our key perspectives on the market dynamics, growth drivers, and valuation considerations, including recent precedent M&A transactions: https://hubs.ly/Q02Bmy3F0
Medical Device Contract Manufacturing Market Outlook - Edgemont
https://www.edgemont.com
-
Edgemont congratulates Zenyth Partners on its recapitalization of LifeCare Home Health Family. Edgemont is pleased to have advised Zenyth Partners on this transaction. For additional information, please see our website here: https://hubs.li/Q02B5bF50 Read the press release: https://hubs.li/Q02B58Q_0
Zenyth Partners has recapitalized LifeCare Home Health Family - Edgemont
edgemont.com
-
Edgemont congratulates BW Health Group on its acquisition by Danforth Advisors, a portfolio company of Avesi Partners. Edgemont is pleased to have advised BW Health Group on this transaction. For additional information, please see our website here: https://hubs.li/Q02z3HNT0
BW Health Group acquired by Danforth Advisors, a portfolio company of Avesi Partners
https://www.edgemont.com
-
Edgemont congratulates CRIO on receiving a significant investment by The Riverside Company. Edgemont is pleased to have advised CRIO on this transaction. For additional information, please see our website here: https://hubs.li/Q02y64tP0 Read the Press Release: https://hubs.li/Q02y5ZzS0
CRIO, Inc. received a significant investment from The Riverside Company - Edgemont
-
Edgemont congratulates Urological Services on its acquisition by Solaris Health, a portfolio company of Lee Equity Partners. Edgemont is pleased to have advised Urological Services on this transaction. For additional information, please see our website here: https://hubs.li/Q02vVfjD0 Read the press release: https://hubs.li/Q02vTQRr0
Urological Services - Edgemont
https://www.edgemont.com
-
Edgemont is pleased to welcome Dan Nicholson to the team as a Managing Director, leading and expanding our Medical Technology coverage efforts! https://hubs.li/Q02tHhL_0
Edgemont Partners Hires Managing Director Dan Nicholson - Edgemont
-
Edgemont Partners reposted this
I'll be speaking at SIIA's (Self-Insurance Institute of America, Inc.) upcoming Corporate Growth Forum. If your company is active in the self-insurance marketplace and could benefit from targeted educational content and/or access to capital to help accelerate your growth, this is a must-attend event. Don't miss this opportunity to join the conversation with me. I look forward to seeing you there! Register Here | https://lnkd.in/ekufnvqQ
-
-
Edgemont congratulates Complete Health Economics Outcomes Research Solutions (dba, CHEORS) on its acquisition by PharmAlliance, a portfolio company of Waud Capital. Edgemont is pleased to have advised CHEORS on this transaction. For additional information, please see our website here: https://hubs.li/Q02t7LZd0 Read the press release: https://hubs.li/Q02t7NQZ0
Complete Health Economics Outcomes Research Solutions (CHEORS) - Edgemont
https://www.edgemont.com